We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Partners to Develop Complex Multilayer Films for Biopharmaceutical Applications

By LabMedica International staff writers
Posted on 21 Jun 2011
Two European manufacturers have signed an exclusive cooperation agreement to develop, manufacture, and supply polymer plastic films for the biopharmaceutical market.

Sartorius Stedim Biotech (Aubagne, France) - a leading provider of equipment and services for development, quality assurance, and production processes in the biopharmaceutical industry - and Südpack Medica AG (Ochsenhausen, Germany) - a manufacturer of innovative packaging solutions that belongs to the Südpack Group - have agreed to form a strategic partnership for an initial term of 10 years.

Südpack will produce plastic film materials for Sartorius Stedim Biotech to be employed in the manufacture of single-use bags and systems. More...
These single-use bags are primarily for laboratory applications by customers in the pharmaceutical industry for cell cultivation, transportation, and storage of biopharmaceutical liquids.

In addition, the two companies will collaborate on the development of novel multilayer films with improved product characteristics. The first product innovations from this cooperation are expected in approximately one year from now.

"Südpack Medica AG has already been developing and manufacturing packaging solutions for medical product manufacturers for many years. Cooperation with Sartorius Stedim Biotech is now an important step into the new, promising markets of the future. We are proud that Sartorius Stedim Biotech, one of the market leaders in the biotechnology industry, has selected us as a partner to jointly develop innovative film laminates. This also tells me that we are on the right track with our strategy of continuously investing in new technologies and developments," said Johannes Remmele, managing director of Südpack.

"Through the alliance with Südpack, we have gained an excellent partner for the development and manufacture of complex multi-layer films that we process in the production of our single-use bags. By supplying innovative single-use products, we are striving to continue offering our customers real added value in the future as well. For this reason, the strategic partnership with Südpack represents a key step for us," said Dr. Oscar-Werner Reif, executive vice president of research and development at Sartorius Stedim Biotech.

Related Links:
Sartorius Stedim Biotech
Südpack Medica AG


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.